Avinger announced the issuance of a new U.S. patent and the allowance of five additional U.S. patents that are expected to issue over the next four months. These patents expand intellectual property protection for Avinger’s proprietary image-guided system and devices for both peripheral and coronary applications. The U.S. Patent and Trademark Office issued U.S. Patent No. 12,089,838 titled “Atherectomy Catheter with Laterally-Displaceable Tip” on September 17, 2024. Avinger has also received notices of allowance from the USPTO for five additional U.S. patents providing coverage for Avinger’s proprietary optical coherence tomography system and image-guided devices, including: U.S. Application no. 18/499,555, Optical Coherence Tomography for Biological Imaging; U.S. Application no. 17/645,722, Atherectomy Catheter Drive Assemblies; U.S. Application no. 17/209,168, Occlusion Crossing Devices; U.S. Application no. 17/455,655, Atherectomy Catheter with Shaped Distal Tip; U.S. Application no. 17/046,066, Occlusion Crossing Devices.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVGR:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue